Tony Vangeneugden

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women

Annaléne Nel, Neliëtte van Niekerk, Saidi Kapiga et al. · New England Journal of Medicine · 2016 · 454 citations · Full text

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48

Roberto Ortiz, Edwin DeJesus, Homayoon Khanlou et al. · AIDS · 2008 · 382 citations

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

José Valdez Madruga, Daniel Berger, Marilyn McMurchie et al. · The Lancet · 2007 · 330 citations

Treatment And Prevention, Antiviral Drug Development, Antiviral Therapy +5

Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1

Christine Katlama, Roberto Esposito, José M. Gatell et al. · AIDS · 2007 · 179 citations · Full text